148 related articles for article (PubMed ID: 5043223)
1. Activity of adriamycin (NSC-123127) and daunomycin (NSC-82151) against mouse mammary carcinoma.
Di Marco A; Lenaz L; Casazza AM; Scarpinato BM
Cancer Chemother Rep; 1972 Apr; 56(2):153-61. PubMed ID: 5043223
[No Abstract] [Full Text] [Related]
2. Adriamycin (NSC-123127) in the treatment of acute myelocytic leukemia.
Cortex EP; Ellison RR; Yates JW
Cancer Chemother Rep; 1972 Apr; 56(2):237-43. PubMed ID: 4504970
[No Abstract] [Full Text] [Related]
3. [Results obtained with the clinical use of adriamycin].
Esposito S; Taylor LA
Haematologica; 1971; 56(9):343-66. PubMed ID: 5004536
[No Abstract] [Full Text] [Related]
4. A new antitumor antibiotic, carminomycin (NSC-180024).
Gause GF; Brazhnikova MG; Shorin VA
Cancer Chemother Rep; 1974; 58(2):255-6. PubMed ID: 4830498
[No Abstract] [Full Text] [Related]
5. A comparison of the cardiovascular actions of daunomycin, adriamycin and N-acetyldaunomycin in hamsters and monkeys.
Herman E; Mhatre R; Lee IP; Vick J; Waravdekar VS
Pharmacology; 1971; 6(4):230-41. PubMed ID: 5002849
[No Abstract] [Full Text] [Related]
6. Different incidence of breast carcinomas or fibroadenomas in daunomycin or adriamycin treated rats.
Bertazzoli C; Chieli T; Solcia E
Experientia; 1971 Oct; 27(10):1209-10. PubMed ID: 5127885
[No Abstract] [Full Text] [Related]
7. Comparison of the antileukemic effect in mice of adriamycin (NSC-123127) with daunomycin (NSC-82151).
Sandberg JS; Howsden FL; DiMarco A; Goldin A
Cancer Chemother Rep; 1970 Feb; 54(1):1-7. PubMed ID: 5527012
[No Abstract] [Full Text] [Related]
8. Clinical use of adriamycin in advanced testicular cancer.
Monfardini S; Bajetta E; Musumeci R; Bonadonna G
J Urol; 1972 Aug; 108(2):293-6. PubMed ID: 5065373
[No Abstract] [Full Text] [Related]
9. Some antineoplastic antibiotics.
Cheng CC; Zee-Cheng KY
J Pharm Sci; 1972 Apr; 61(4):485-501. PubMed ID: 4111335
[No Abstract] [Full Text] [Related]
10. Comparative pharmacokinetics of daunomycin and adriamycin in several animal species.
Yesair DW; Schwartzbach E; Shuck D; Denine EP; Asbell MA
Cancer Res; 1972 Jun; 32(6):1177-83. PubMed ID: 5030818
[No Abstract] [Full Text] [Related]
11. [Possibility of utilizing lymphatic leukemia L1210 as a first screening model in the primary selection of new antitumor antibiotics].
Shorin VA; Bazhanov VS
Antibiotiki; 1974 Aug; 19(8):679-84. PubMed ID: 4455117
[No Abstract] [Full Text] [Related]
12. The anthracycline antineoplastic drugs.
Young RC; Ozols RF; Myers CE
N Engl J Med; 1981 Jul; 305(3):139-53. PubMed ID: 7017406
[No Abstract] [Full Text] [Related]
13. Distribution and metabolism of adriamycin in mice. Comparison with daunomycin.
Di Fronzo G; Gambetta RA; Lenaz L
Rev Eur Etud Clin Biol; 1971; 16(6):572-6. PubMed ID: 5125106
[No Abstract] [Full Text] [Related]
14. Inhibition of DNA and RNA metabolism by daunorubicin and adriamycin in L1210 mouse leukemia.
Meriwether WD; Bachur NR
Cancer Res; 1972 Jun; 32(6):1137-42. PubMed ID: 5030814
[No Abstract] [Full Text] [Related]
15. Modification of transplantability and tumor growth following treatment of L1210 leukemia and TA3Ha cells with macromomycin (NSC-170105).
Lippman MM; Abbott BJ
Cancer Chemother Rep; 1973; 57(4):501-3. PubMed ID: 4762442
[No Abstract] [Full Text] [Related]
16. Activity of anthracyclines against an adriamycin (NSC-123127)-resistant subline of P388 leukemia with special emphasis on cinerubin A (NSC-18334).
Johnson RK; Ovejera AA; Goldin A
Cancer Treat Rep; 1976 Jan; 60(1):99-102. PubMed ID: 826316
[No Abstract] [Full Text] [Related]
17. Anthracyclines in the treatment of acute nonlymphocytic leukemias.
Boiron M; Jacquillat C; Marty M; Weil M; Gisselbrecht C
Cancer Treat Rep; 1981; 65 Suppl 4():73-6. PubMed ID: 6955013
[No Abstract] [Full Text] [Related]
18. Cytotoxic, antiviral, and antitumor activity of some derivatives of daunomycin (NSC-82151).
Di Marco A; Casazza AM; Dasdia T; Giuliani F; Lenaz L; Necco A; Soranzo C
Cancer Chemother Rep; 1973; 57(3):269-74. PubMed ID: 4751254
[No Abstract] [Full Text] [Related]
19. Use of first generation transplants of a slow growing solid tumor for the evaluation of new cancer chemotherapeutic agents.
Sandberg J; Goldin A
Cancer Chemother Rep; 1971 Jun; 55(3):233-8. PubMed ID: 5115845
[No Abstract] [Full Text] [Related]
20. [Research on optimal dosage schemes in clinical experimentation with antineoplastic agents].
Praga C
Boll Chim Farm; 1972 Feb; 111(2):93-9. PubMed ID: 4505372
[No Abstract] [Full Text] [Related]
[Next] [New Search]
